Related references
Note: Only part of the references are listed.Commonalities in epileptogenic processes from different acute brain insults: Do they translate?
Pavel Klein et al.
EPILEPSIA (2018)
Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet
Gaetano Terrone et al.
EPILEPSIA (2018)
Detection of Cyclooxygenase-2-Derived Oxygenation Products of the Endogenous Cannabinoid 2-Arachidonoylglycerol in Mouse Brain
Amanda J. Morgan et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Discovery of novel Methylsulfonyl phenyl derivatives as potent human Cyclooxygenase-2 inhibitors with effective anticonvulsant action: Design, synthesis, in-silico, in-vitro and in-vivo evaluation
Chandra Bhushan Mishra et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Antiepileptogenic Effect of Subchronic Palmitoylethanolamide Treatment in a Mouse Model of Acute Epilepsy
Julia M. Post et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Neuroinflammatory targets and treatments for epilepsy validated in experimental models
Eleonora Aronica et al.
EPILEPSIA (2017)
EP2 receptor antagonism reduces peripheral and central hyperalgesia in a preclinical mouse model of endometriosis
Erin Greaves et al.
SCIENTIFIC REPORTS (2017)
Prostaglandin E2-EP2 signaling as a node of chronic inflammation in the colon tumor microenvironment
Tomohiro Aoki et al.
INFLAMMATION AND REGENERATION (2017)
Acute effects of aceclofenac, COX-2 inhibitor, on penicillin-induced epileptiform activity
Mehmet Taskiran et al.
BRAIN RESEARCH BULLETIN (2017)
Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in rats
Asheebo Rojas et al.
NEUROPHARMACOLOGY (2016)
Candidate Drug Targets for Prevention or Modification of Epilepsy
Nicholas H. Varvel et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG/Rij rats
Rita Citraro et al.
BRAIN RESEARCH BULLETIN (2015)
Anticonvulsant activity of the cyclooxygenase-2 (COX-2) inhibitor etoricoxib in pentylenetetrazole-kindled rats is associated with memory impairment
Jatinder Katyal et al.
EPILEPSY & BEHAVIOR (2015)
A Large-Scale Study Indicates Increase in the Risk of Epilepsy in Patients With Different Risk Factors, Including Rheumatoid Arthritis
Kuang-Hsi Chang et al.
MEDICINE (2015)
Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus
Jianxiong Jiang et al.
NEUROBIOLOGY OF DISEASE (2015)
Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus
Asheebo Rojas et al.
NEUROPHARMACOLOGY (2015)
Evidence That Links Loss of Cyclooxygenase-2 With Increased Asymmetric Dimethylarginine Novel Explanation of Cardiovascular Side Effects Associated With Anti-Inflammatory Drugs
Blerina Ahmetaj-Shala et al.
CIRCULATION (2015)
Prostaglandin D2 is crucial for seizure suppression and postictal sleep
Mahesh K. Kaushik et al.
EXPERIMENTAL NEUROLOGY (2014)
Prostanoid Receptor EP2 as a Therapeutic Target
Thota Ganesh
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Lead Optimization Studies of Cinnamic Amide EP2 Antagonists
Thota Ganesh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Central CRTH2, a Second Prostaglandin D2 Receptor, Mediates Emotional Impairment in the Lipopolysaccharide and Tumor-Induced Sickness Behavior Model
Ryota Haba et al.
JOURNAL OF NEUROSCIENCE (2014)
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
Ye Zhang et al.
JOURNAL OF NEUROSCIENCE (2014)
The prostaglandin EP1 receptor potentiates kainate receptor activation via a protein kinase C pathway and exacerbates status epilepticus
Asheebo Rojas et al.
NEUROBIOLOGY OF DISEASE (2014)
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators
Mireille Alhouayek et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Aspirin Use in Sturge-Weber Syndrome: Side Effects and Clinical Outcomes
Eboni I. Lance et al.
JOURNAL OF CHILD NEUROLOGY (2013)
Prostaglandin F2α FP receptor antagonist improves outcomes after experimental traumatic brain injury
Alexander V. Glushakov et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Oxidative Burst of Circulating Neutrophils Following Traumatic Brain Injury in Human
Yiliu Liao et al.
PLOS ONE (2013)
Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation
Jianxiong Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection
Jianxiong Jiang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Recent Progress in Prostaglandin F2α Ethanolamide (Prostamide F2α) Research and Therapeutics
D. F. Woodward et al.
PHARMACOLOGICAL REVIEWS (2013)
EP2 and EP4 receptors on muscularis resident macrophages mediate LPS-induced intestinal dysmotility via iNOS upregulation through cAMP/ERK signals
Tsuyoshi Tajima et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Reduction in delayed mortality and subtle improvement in retrograde memory performance in pilocarpine-treated mice with conditional neuronal deletion of cyclooxygenase-2 gene
Jamie R. Levin et al.
EPILEPSIA (2012)
Prostaglandin FP receptor inhibitor reduces ischemic brain damage and neurotoxicity
Yun Tai Kim et al.
NEUROBIOLOGY OF DISEASE (2012)
IMMUNOHISTOCHEMICAL DEMONSTRATION OF INCREASED PROSTAGLANDIN F2α LEVELS IN THE RAT HIPPOCAMPUS FOLLOWING KAINIC ACID-INDUCED SEIZURES
S. Takei et al.
NEUROSCIENCE (2012)
Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2
Jianxiong Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Prostaglandins and Inflammation
Emanuela Ricciotti et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Cyclooxygenase-2 inhibitors: a literature and patent review (2009-2010)
Baker Jawabrah Al-Hourani et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Ablation of Cyclooxygenase-2 in Forebrain Neurons is Neuroprotective and Dampens Brain Inflammation after Status Epilepticus
G. E. Serrano et al.
JOURNAL OF NEUROSCIENCE (2011)
Estimating risk for developing epilepsy A population-based study in Rochester, Minnesota
D. C. Hesdorffer et al.
NEUROLOGY (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation
Daniel K. Nomura et al.
SCIENCE (2011)
Emotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga
Tilo Grosser et al.
ANNUAL REVIEW OF MEDICINE (2010)
Modulating P-glycoprotein regulation: Future perspectives for pharmacoresistant epilepsies?
Heidrun Potschka
EPILEPSIA (2010)
Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy
Linda Holtman et al.
EPILEPSY RESEARCH (2010)
The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy
Nadine Polascheck et al.
EXPERIMENTAL NEUROLOGY (2010)
Induction of COX-2/PGE2/IL-6 is crucial for cigarette smoke extract-induced airway inflammation: Role of TLR4-dependent NADPH oxidase activation
Chih-Chung Lin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats
Erwin A. van Vliet et al.
NEUROPHARMACOLOGY (2010)
Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy
L. Holtman et al.
EPILEPSY RESEARCH (2009)
Targeting Prostaglandin E2 EP1 Receptors Prevents Seizure-Associated P-glycoprotein Up-Regulation
Anton Pekcec et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
PGF(2 alpha) FP Receptor Contributes to Brain Damage Following Transient Focal Brain Ischemia
Sofiyan Saleem et al.
NEUROTOXICITY RESEARCH (2009)
Involvement of endogenous prostaglandin F2α on kainic acid-induced seizure activity through FP receptor:: The mechanism of proconvulsant effects of COX-2 inhibitors
Hee-Jae Kim et al.
BRAIN RESEARCH (2008)
Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation - Potential implications for cyclooxygenase-2 inhibition
Eric Arehart et al.
CIRCULATION RESEARCH (2008)
Cyclooxygenase-2/PGE2 pathway facilitates pentylenetetrazol-induced seizures
Mauro Schneider Oliveira et al.
EPILEPSY RESEARCH (2008)
Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: Possible involvement of adenosinergic mechanism
Kiran Kumar Akula et al.
EPILEPSY RESEARCH (2008)
Central prostaglandin D2 stimulates food intake via the neuropeptide Y system in mice
Kousaku Ohinata et al.
FEBS LETTERS (2008)
Modulation of pentylenetetrazol-induced seizures by prostaglandin E2 receptors
M. S. Oliveira et al.
NEUROSCIENCE (2008)
Neuronal cyclooxygenase-2 activity and prostaglandins PGE2, PGD2, and PGF2 alpha exacerbate hypoxic neuronal injury in neuron-enriched primary culture
Wenjin Li et al.
NEUROCHEMICAL RESEARCH (2008)
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial
Li-Yan Khor et al.
LANCET ONCOLOGY (2007)
Gastroenterology 1 - Inflammatory bowel disease: cause and immunobiology
Daniel C. Baumgart et al.
LANCET (2007)
Prostaglandin E receptors
Yukihiko Sugimoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Natural history and magnetic resonance imaging follow-up in 9 Sturge-Weber Syndrome patients and clinical correlation
Vrajesh Udani et al.
JOURNAL OF CHILD NEUROLOGY (2007)
Prostaglandin E2 produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region
Takako Takemiya et al.
NEUROSCIENCE RESEARCH (2006)
Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus
Keun-Hwa Jung et al.
NEUROBIOLOGY OF DISEASE (2006)
Lipocalin-type prostaglandin D synthase is up-regulated in oligodendrocytes in lysosomal storage diseases and binds gangliosides
I Mohri et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in CA3 hippocampus
K Kawaguchi et al.
BRAIN RESEARCH (2005)
Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia
D Liu et al.
ANNALS OF NEUROLOGY (2005)
Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia
L McCullough et al.
JOURNAL OF NEUROSCIENCE (2004)
COX-2-derived prostacyclin confers atheroprotection on female mice
KM Egan et al.
SCIENCE (2004)
Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration
OL Gobbo et al.
NEUROSCIENCE (2004)
Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase
CE Trebino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling
T Takemiya et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2003)
Hematopoietic prostaglandin D synthase is expressed in microglia in the developing postnatal mouse brain
I Mohri et al.
GLIA (2003)
Prostaglandin F synthase
K Watanabe
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
Perineuronal oligodendrocytes protect against neuronal apoptosis through the production of lipocalin-type prostaglandin D synthase in a genetic demyelinating model
M Taniike et al.
JOURNAL OF NEUROSCIENCE (2002)
Pharmacological characterization of the anandamide cyclooxygenase metabolite:: Prostaglandin E2 ethanolamide
RA Ross et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Pharmacology of cyclooxygenase-2 inhibition in the kidney
KNM Khan et al.
KIDNEY INTERNATIONAL (2002)
Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep
A Mizoguchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Therapeutic potential of COX-2 inhibitors in arthritis
CG Jackson
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2001)
The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus
T Kunz et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Share Paper
